Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C21H36O5 |
| Molecular Weight | 368.5083 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 4 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
InChI
InChIKey=CNWGPXZGIIOYDL-MKYGPDKMSA-N
InChI=1S/C21H36O5/c1-3-4-13-21(2,26)14-9-11-17-16(18(22)15-19(17)23)10-7-5-6-8-12-20(24)25/h9,11,16-17,19,23,26H,3-8,10,12-15H2,1-2H3,(H,24,25)/b11-9+/t16-,17-,19-,21?/m1/s1
| Molecular Formula | C21H36O5 |
| Molecular Weight | 368.5083 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 4 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:05:56 GMT 2025
by
admin
on
Mon Mar 31 23:05:56 GMT 2025
|
| Record UNII |
12Z0SU967A
|
| Record Status |
FAILED
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
66792-31-2
Created by
admin on Mon Mar 31 23:05:56 GMT 2025 , Edited by admin on Mon Mar 31 23:05:56 GMT 2025
|
PRIMARY | |||
|
Misoprostol acid
Created by
admin on Mon Mar 31 23:05:56 GMT 2025 , Edited by admin on Mon Mar 31 23:05:56 GMT 2025
|
PRIMARY | |||
|
DTXSID601347869
Created by
admin on Mon Mar 31 23:05:56 GMT 2025 , Edited by admin on Mon Mar 31 23:05:56 GMT 2025
|
PRIMARY | |||
|
6436406
Created by
admin on Mon Mar 31 23:05:56 GMT 2025 , Edited by admin on Mon Mar 31 23:05:56 GMT 2025
|
PRIMARY | |||
|
12Z0SU967A
Created by
admin on Mon Mar 31 23:05:56 GMT 2025 , Edited by admin on Mon Mar 31 23:05:56 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
OFF TARGET->NON-INHIBITOR |
Ki
|
||
|
BINDER->LIGAND |
Less than 90% and is concentration-independent in the therapeutic range.
BINDING
|
||
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
